Aer Therapeutics
PrivateLast Round
Seed Round
Aug 7, 2026
Total Funding Raised
$36M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Aer Therapeutics operates in Healthcare & Life Sciences and is based in Raleigh, North Carolina. Its latest recorded funding round was a Series A round in April 2023.
Aer Therapeutics is a biotechnology company that develops inhaled mucolytic therapies for the treatment of muco-obstructive lung diseases such as COPD and asthma.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aer Therapeutics Comparables
Compare Aer Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Renovion, Inc. | 85% | |
| AlgiPharma AS | 82% | |
| MucoLife Therapeutics | 79% |
For institutional investors. Book with your work email.
Aer Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Aug 7, 2026 | ||||
| Series A | Apr 13, 2023 |
For institutional investors. Book with your work email.
Aer Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Series A |
| Hatteras Venture Partners | Series A |
| OrbiMed | Series A |
| Canaan Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 7, 2026
Raised $3M in a Seed Round.
- Jul 27, 2026
Monthly visitors increased 145% MoM.
For institutional investors. Book with your work email.
Aer Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aer Therapeutics's valuation, stock price, and market status.
Is Aer Therapeutics a public or private company?
Aer Therapeutics is a private company.
What is the current stock price of Aer Therapeutics?
Aer Therapeutics is a private company, so its shares have no public market price. Caplight tracks Aer Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aer Therapeutics worth (valuation)?
Valuation information for Aer Therapeutics is not publicly available.
Can I buy Aer Therapeutics stock?
Aer Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aer Therapeutics's last funding round?
Aer Therapeutics's most recent funding round was Seed Round on August 7, 2026.
Who are the main investors in Aer Therapeutics?
Key investors in Aer Therapeutics include NIH RADx, Hatteras Venture Partners, OrbiMed, Canaan Partners.
Will Aer Therapeutics IPO soon?
No public IPO plans have been announced for Aer Therapeutics.
How can I track Aer Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Aer Therapeutics's shares on secondary markets.